The study's objective is to come up with a description of the international financial ecosystem surrounding the development of novel medicines (R&D). This entails charting the types of public and private players involved in research and development of medicines, ascertaining how the research agenda is prepared, establishing the strategies, mechanisms, incentives and drivers of the actors, including investors, as well as how national and international funding for new medicines (including investments and disinvestments, returns, etc.) is shaped.
Tjänster
2020-08-27 10:00:00
73000000-2 FoU-tjänster samt tillhörande konsulttjänster
73110000-6 Forskning
73200000-4 FoU-rådgivning
79311400-1 Ekonomiska undersökningar
71620000-0 Analystjänster
66170000-2 Finansiell rådgivning, hantering av finansiella transaktioner och clearinghouse-tjänster
| Annons | Utsändningsdatum |
|---|---|
| [TNV3F02ContractNotice] (TenderNed) | 2020-04-29 16:00 |
[TNV3F14Corrigendum] (TenderNed)
|
2020-06-24 13:23 |
| [TNV3F03ContractAwardNotice] (TenderNed) | 2021-07-21 16:30 |